p21waf correlates with DNA replication but not with prognosis in invasive breast cancer

Journal of Clinical Pathology

Volumn 54, Issue 11, 2001, Pages 866-870

  Gohring U J ^a   Bersch, A ^a   Becker, M ^a   Neuhaus, W ^a   Schondorf T ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Breast cancer; Immunohistochemistry; p53; Prognosis; Proliferating cell nuclear antigen

Indexed keywords

BIOCHEMICAL MARKER; CYCLINE; MONOCLONAL ANTIBODY; PROTEIN P21; PROTEIN P53; RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; DNA REPLICATION; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIVARIATE ANALYSIS; ONCOGENE NEU; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGRESSION ANALYSIS; TUMOR VOLUME;

EID: 0035168921     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.11.866     Document Type: Article

References (34)

1. Cancer cell cycles
2. Cell cycle regulators: Mechanisms and their role in aetiology, prognosis and treatment of cancer
3. Cell cycle regulators and their abnormalities in breast cancer
4. The expanding role of cell cycle regulators
5. WAF1, a potential mediator of p53 tumour suppression
6. p21 is a universal inhibitor of cyclin kinases
7. 1 arrest and apoptosis
8. WAF1/CIP1 expression in normal and neoplastic tissues
9. WAF1/CIP1
10. Induction of p21 (WAF1/CIP1) during differentiation
11. Waf1 in NIH3T3 cells
12. 2
13. 2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for rereplication
14. Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas
15. WAF1/CIP1 expression and induces S-phase entry in 12-o-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells
16. WAF1
17. WAF1/CIP1 enhances tumour cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer model
18. erbB2 - A marker for poor prognosis in primary breast cancer
19. Detection of proliferating cell nuclear antigen in primary breast carcinoma - A proliferation marker as a prognostic factor in nodal-positive patients
20. p53 protein in primary breast carcinoma - Immunohistochemical detection and clinical value as prognostic factor
21. P21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis
22. CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma
23. WAF1/CIP1 in breast epithelial cells
24. Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53
25. p21(WAF1) expression and endocrine response in breast cancer
26. P21 (Waf1/Cip1) and p53 protein expression in breast cancer
27. WAF1 immunohistochemical expression
28. Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: An immunohistochemical study in 261 patients with long-term follow-up
29. Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients
30. Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with anthracyclin
31. Prognostic and predictive value of p53 and p21 in breast cancer
32. Cdk-interacting protein 1 directly binds with proliferation cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase δ holoenzyme
33. Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into DNA replication complex
34. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair